Clinical Trial Update: Omega 3 Fatty Acid Trial [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of omega-3 fatty acids for pediatric bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Mayo Clinic | Conditions: Omega-3 Fatty Acids, Pediatric Bipolar Disorder | Phase 1 | Status: COMPLETED